CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | ABERNETHY MATT Chief Financial Officer | Sale 10b5-1 | −2,311 | $157.20 | $363K | 42,808 |
| 2026-09-11 | ABERNETHY MATT Chief Financial Officer | Grant or award 10b5-1 | +5,020 | 47,828 | ||
| 2026-09-11 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes 10b5-1 | −2,709 | $156.22 | $423K | 45,119 |
| 2026-03-04 | ABERNETHY MATT Chief Financial Officer | Gift | −2,249 | 42,808 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Option exercise | +2,241 | 40,320 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes | −1,210 | $124.12 | $150K | 39,110 |
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Option exercise | +2,566 | 41,676 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes | −1,385 | $124.12 | $172K | 40,291 |
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Grant or award | +9,968 | 50,259 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes | −5,378 | $124.12 | $668K | 44,881 |
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,241 | 4,484 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,566 | 2,566 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Grant or award · Stock Option | +44,095 | 44,095 | ||
| 2026-02-13 | ABERNETHY MATT Chief Financial Officer | Grant or award · Restricted Stock Unit | +7,735 | 7,735 | ||
| 2026-02-12 | ABERNETHY MATT Chief Financial Officer | Option exercise | +2,133 | 39,230 | ||
| 2026-02-12 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes | −1,151 | $123.10 | $142K | 38,079 |
| 2026-02-12 | ABERNETHY MATT Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,133 | 6,401 | ||
| 2026-01-31 | ABERNETHY MATT Chief Financial Officer | Option exercise | +2,437 | 38,465 | ||
| 2026-01-31 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes | −1,368 | $136.06 | $186K | 37,097 |
| 2026-01-31 | ABERNETHY MATT Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,437 | 0 |
Page 1 of 3 · 46 trades